EUVIMEDEUVIMED entdecken
Crossref

Healthcare Providers' Vaccination Against COVID-19: Safety Concerns

Elham Rezaee Zavareh, Shafagh Aliasgarzadeh, Javad Ali Asgarzadeh, Ghazale Farhadi, Sevda Mikaeili Mirak

International Pharmacy Acta · 31.07.2024

DOI: 10.22037/ipa.v7i1.45396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Pharmacy Acta, erschienen am 31.07.2024. Verfasst von Elham Rezaee Zavareh und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examined parameters that may affect the severity and type of side effects associated with COVID-19 vaccine administration at Imam Khomeini Hospital in Ardabil, Iran. Based on a reliable and valid questionnaire, data were collected from 149 hospital employees at random. 77.2% of the study participants were women, and 52% were between the ages of 30-39. Approximately 50% of the participants had a healthy body mass index. Of the participants, 76.5% had no underlying disease. The prevalence of complications after injection of the first dose (regardless of vaccine type) included fever (45%), chills (28.3%), injection site complications (34.9%), myalgia (46.3%), weakness and fatigue (43%), headache (24.2%), thrombocytopenia (1.3%), cough (4%), nausea (6.7%), diarrhea (6.7%), and other complications (5.4%). After receiving a second dose, the most frequently reported adverse reactions were fatigue and weakness. This pattern was repeated for third dose. Injection of the first dose of vaccine induced the most severe side effects. The results demonstrated a significant relationship between severity and duration of side effects and participants' age, sex, body mass index, diet quality, physical activity, and complementary medicines. Participants with underlying health conditions and those using corticosteroids had higher adverse effects incidences. A significant positive correlation (0.878%) was observed between fever severity and chills. SputnikV and AstraZeneca vaccines were associated with more side effects. In general, the rate and severity of side effects after vaccination are directly related to female gender, low body mass index, previous infection, and young age.

Schlagwörter

COVID-19 vaccinationvaccine adverse eventshealthcare workersvaccine side effectsfever and chillsinjection site reactionsmyalgiafatigueSputnik VChAdOx1 nCoV-19 vaccine

Zitieren

APA

Zavareh, E. R., Aliasgarzadeh, S., Asgarzadeh, J. A., Farhadi, G., & Mirak, S. M. (2024). Healthcare Providers' Vaccination Against COVID-19: Safety Concerns. International Pharmacy Acta. https://doi.org/10.22037/ipa.v7i1.45396

Vancouver

Zavareh ER, Aliasgarzadeh S, Asgarzadeh JA, Farhadi G, Mirak SM. Healthcare Providers' Vaccination Against COVID-19: Safety Concerns. International Pharmacy Acta. 2024. doi:10.22037/ipa.v7i1.45396

BibTeX
@article{Zavareh2024,
  author = {Zavareh, Elham Rezaee and Aliasgarzadeh, Shafagh and Asgarzadeh, Javad Ali and Farhadi, Ghazale and Mirak, Sevda Mikaeili},
  title = {Healthcare Providers' Vaccination Against COVID-19: Safety Concerns},
  journal = {International Pharmacy Acta},
  year = {2024},
  doi = {10.22037/ipa.v7i1.45396}
}
Kostenlos starten →